An Oxford University biotech spinout, and an innovative collaboration between Immunology, Vaccine and Oncology experts. Exploiting a CRUK-patented vaccine with excellent preclinical results. The venture has been funded to advance the technology into phase I/IIa clinical trials.

Contact Us

Please use the form below to get in touch with us!